In vitro activity of imipenem-relebactam against gram-negative ESKAPE pathogens isolated by clinical laboratories in the United States in 2015 (results from the SMART Global Surveillance Program) - Lob, S H; Hackel, M A; Kazmierczak, K M (Antimicrob Agents Chemother, 2017)